127 related articles for article (PubMed ID: 34338582)
1. Acriflavine-loaded solid lipid nanoparticles: preparation, physicochemical characterization, and anti-proliferative properties.
Vandghanooni S; Rasoulian F; Eskandani M; Akbari Nakhjavani S; Eskandani M
Pharm Dev Technol; 2021 Nov; 26(9):934-942. PubMed ID: 34338582
[TBL] [Abstract][Full Text] [Related]
2. Preparation, physicochemical characterization, and anti-proliferative properties of Lawsone-loaded solid lipid nanoparticles.
Rasouliyan F; Eskandani M; Jaymand M; Akbari Nakhjavani S; Farahzadi R; Vandghanooni S; Eskandani M
Chem Phys Lipids; 2021 Sep; 239():105123. PubMed ID: 34403685
[TBL] [Abstract][Full Text] [Related]
3. Formulation, characterization, and geno/cytotoxicity studies of galbanic acid-loaded solid lipid nanoparticles.
Eskandani M; Barar J; Dolatabadi JE; Hamishehkar H; Nazemiyeh H
Pharm Biol; 2015; 53(10):1525-38. PubMed ID: 25853953
[TBL] [Abstract][Full Text] [Related]
4. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
5. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of acriflavine in lung adenocarcinoma cell line A549.
Lee CJ; Yue CH; Lin YJ; Lin YY; Kao SH; Liu JY; Chen YH
Anticancer Res; 2014 Nov; 34(11):6467-72. PubMed ID: 25368247
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of l-carnitine-loaded solid lipid nanoparticles against H
Eskandani M; Eskandani M; Vandghanooni S; Navidshad B; Aghjehgheshlagh FM; Nobakht A
Colloids Surf B Biointerfaces; 2022 Apr; 212():112365. PubMed ID: 35124408
[TBL] [Abstract][Full Text] [Related]
8. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
[TBL] [Abstract][Full Text] [Related]
9. Development and characterization of Brigatinib loaded solid lipid nanoparticles: In-vitro cytotoxicity against human carcinoma A549 lung cell lines.
Ahmed MM; Fatima F; Anwer MK; Aldawsari MF; Alsaidan YSM; Alfaiz SA; Haque A; Az A; Alhazzani K
Chem Phys Lipids; 2020 Nov; 233():105003. PubMed ID: 33096096
[TBL] [Abstract][Full Text] [Related]
10. Aloe-emodin loaded solid lipid nanoparticles: formulation design and in vitro anti-cancer study.
Chen R; Wang S; Zhang J; Chen M; Wang Y
Drug Deliv; 2015; 22(5):666-74. PubMed ID: 24512431
[TBL] [Abstract][Full Text] [Related]
11. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
12. Marrubiin-loaded solid lipid nanoparticles' impact on TNF-α treated umbilical vein endothelial cells: A study for cardioprotective effect.
Nakhlband A; Eskandani M; Saeedi N; Ghafari S; Omidi Y; Barar J; Garjani A
Colloids Surf B Biointerfaces; 2018 Apr; 164():299-307. PubMed ID: 29413609
[TBL] [Abstract][Full Text] [Related]
13. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
14. Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles.
Ezzati Nazhad Dolatabadi J; Hamishehkar H; Eskandani M; Valizadeh H
Colloids Surf B Biointerfaces; 2014 May; 117():21-8. PubMed ID: 24607519
[TBL] [Abstract][Full Text] [Related]
15. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
16. Promoted Antitumor Activity of Myricetin against Lung Carcinoma Via Nanoencapsulated Phospholipid Complex in Respirable Microparticles.
Nafee N; Gaber DM; Elzoghby AO; Helmy MW; Abdallah OY
Pharm Res; 2020 Apr; 37(4):82. PubMed ID: 32291520
[TBL] [Abstract][Full Text] [Related]
17. Formulation and Physicochemical Characterization of Lycopene-Loaded Solid Lipid Nanoparticles.
Nazemiyeh E; Eskandani M; Sheikhloie H; Nazemiyeh H
Adv Pharm Bull; 2016 Jun; 6(2):235-41. PubMed ID: 27478786
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation.
Mahmoudian M; Valizadeh H; Zakeri-Milani P
Drug Dev Ind Pharm; 2018 Oct; 44(10):1598-1605. PubMed ID: 29874944
[TBL] [Abstract][Full Text] [Related]
19. Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles.
You J; Wan F; de Cui F; Sun Y; Du YZ; Hu FQ
Int J Pharm; 2007 Oct; 343(1-2):270-6. PubMed ID: 17706383
[TBL] [Abstract][Full Text] [Related]
20. Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles.
Sun Q; Li W; Li H; Wang X; Wang Y; Niu X
Pharmacology; 2017; 100(1-2):14-24. PubMed ID: 28334726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
